These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12538468)

  • 41. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
    Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis.
    Micke P; Hengstler JG; Ros R; Bittinger F; Metz T; Gebhard S; Beeh KM; Oesch F; Buhl R
    Int J Cancer; 2001 May; 92(4):474-9. PubMed ID: 11304679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Pflugfelder L; Geddert H; Müller W; Steidl U; Fenk R; Gräf T; Schott M; Thiele KP; Gabbert HE; Germing U; Kronenwett R; Haas R
    Int J Cancer; 2004 Aug; 111(2):259-63. PubMed ID: 15197780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression.
    Lassen UN; Osterlind K; Hirsch FR; Bergman B; Dombernowsky P; Hansen HH
    Br J Cancer; 1999 Feb; 79(3-4):515-9. PubMed ID: 10027322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.
    Sekido Y; Takahashi T; Ueda R; Takahashi M; Suzuki H; Nishida K; Tsukamoto T; Hida T; Shimokata K; Zsebo KM
    Cancer Res; 1993 Apr; 53(7):1709-14. PubMed ID: 7680956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
    Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
    Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival of patients with small cell lung carcinoma in Taiwan.
    Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
    Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A new strategy for treating small cell lung cancer].
    Ueda R; Takashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():111-4. PubMed ID: 9216197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
    Ruotsalainen T; Joensuu H; Mattson K; Salven P
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1492-5. PubMed ID: 12433733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
    DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
    Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic factors of small-cell bronchial carcinoma].
    Kelbel C; Omid S; Westermeier T; Lorenz J
    Pneumologie; 1994 Jul; 48(7):475-80. PubMed ID: 7937656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Saji H; Kakihana M; Kajiwara N; Uchida O; Nomura M; Ohira T; Ikeda N
    Lung Cancer; 2011 Nov; 74(2):332-7. PubMed ID: 21529984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prognostic model and staging for metastatic uveal melanoma.
    Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
    Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. c-kit expression in adenocarcinomas of the lung.
    Micke P; Hengstler JG; Albrecht H; Faldum A; Bittinger F; Becker K; Wiewrodt R; Fischer B; Buhl R
    Tumour Biol; 2004; 25(5-6):235-42. PubMed ID: 15627886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Has lung cancer in the elderly different characteristics at presentation?
    Montella M; Gridelli C; Crispo A; Scognamiglio F; Ruffolo P; Gatani T; Boccia V; Maione P; Fabbrocini G
    Oncol Rep; 2002; 9(5):1093-6. PubMed ID: 12168079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
    Kim AW; Batus M; Myint R; Fidler MJ; Basu S; Bonomi P; Faber LP; Wightman SC; Warren WH; McIntire M; Arvanitis LD; Gattuso P; Xu X; Liptay MJ
    Lung Cancer; 2011 Feb; 71(2):186-90. PubMed ID: 20570389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
    LaPoint RJ; Bourne PA; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.